Back to Prevention

Who Should Avoid Lenacapavir?

Who Should Avoid Lenacapavir?
Bareback Guide 19 August 2026

Lenacapavir is suited to people for whom taking something regularly is the obstacle, and it is a poor fit for several situations. Because a dose cannot be withdrawn, getting that judgement right beforehand matters more than usual.

Who is excluded by interactions?

Anyone taking rifampicin for tuberculosis, and anyone on a strong enzyme-inducing anticonvulsant such as carbamazepine, phenytoin or phenobarbital. These reduce levels enough to risk failure and resistance, and the exposure cannot be reversed once injected.

Who is excluded by attendance?

Anyone who cannot reliably attend twice a year within the dosing window. That sounds undemanding and the six-month gap is precisely what makes it easy to let drift. Anyone whose contact with services is intermittent may be better served by something with a shorter, more visible rhythm.

What about injections themselves?

Anyone with a strong needle phobia, though this is worth exploring rather than accepting, since two appointments a year is a small exposure. Anyone with a bleeding disorder or on anticoagulation needs the injection planned rather than ruled out.

What about previous drug reactions?

Any documented hypersensitivity to lenacapavir excludes it. A history of serious reactions to medicines generally is a reason for caution and for using the oral initiation period to assess tolerability before the depot is established.

What about severe liver or kidney impairment?

No adjustment is needed for mild to moderate impairment of either. Severe impairment has been less studied and is a specialist decision rather than something to assume in either direction.

What about pregnancy?

Data are limited, and the persistence in the body for months after the last dose is a particular consideration for anyone who might become pregnant. Prevention trials did include women of childbearing age, which has added to what is known. This warrants a specific conversation rather than a general answer.

What about existing resistance?

For treatment, lenacapavir is chosen precisely because capsid resistance is rare, and any known capsid mutations would change the picture. Resistance testing informs whether it is appropriate and what should accompany it.

What about hepatitis B?

Lenacapavir has no activity against hepatitis B. Anyone with chronic hepatitis B who is currently covered by a tenofovir-containing regimen must not lose that cover, which is a specific point to raise before any switch.

What are the alternatives for prevention?

Daily or event-based oral PrEP with tenofovir disoproxil and emtricitabine, which is the UK standard and free. Injectable cabotegravir every two months where commissioned. Condoms and a partner with a sustained undetectable viral load remain fully effective.

What are the alternatives for resistant HIV?

Other agents active against resistant virus exist, and the appropriate combination depends entirely on the specific resistance pattern. This is a specialist decision made with resistance testing rather than from a list.

What is worth confirming?

Availability. Commissioning for prevention has been developing and differs by area, so what your clinic can actually offer is the practical starting point rather than what exists in principle.

Is the oral form an alternative?

Not as a long-term option. The tablets exist for initiation and bridging rather than as a standalone regimen. If injections are not right for you, the answer is a different drug rather than the oral form of this one.

What should you tell your service?

Everything you take, including over-the-counter and herbal products, any previous drug reactions, your hepatitis B status, and an honest view of whether you will attend twice a year. With a six-month depot, that conversation carries more weight than it does for a tablet.

What if it is the only option available?

Rarely the case. HIV medicine now has enough options that almost every situation has an alternative, and where choices genuinely are limited a specialist will construct something around your resistance profile. Being told there is nothing else is worth a second opinion.

Who decides?

You do, with a clinician. Suitability is a clinical judgement and the choice between suitable options is yours, including on grounds like convenience, appearance of tablets or how a schedule fits your life. Those are legitimate reasons rather than trivial ones.